Searchable abstracts of presentations at key conferences in endocrinology

ea0029p278 | Cardiovascular Endocrinology and Lipid Metabolism | ICEECE2012

Transient glucocorticoid excess does not cause persisting metabolic changes in mice

Auvinen H. , Romijn J. , Biermasz N. , Boon M. , Havekes L. , Smit J. , Rensen P. , Pereira A.

Introduction: In humans, Cushing’s syndrome (CS) is associated with an increased incidence of the metabolic syndrome, increased cardiovascular morbidity and mortality, even after long-term correction of glucocorticoid (GC) excess.Aim: To evaluate the effects of transient overexposure to GC on the metabolic changes in the long-term in mice.Methods: Single housed male C57Bl/6J mice were given corticosterone (CORT; 50 μg/ml)...

ea0029p1453 | Pituitary Clinical | ICEECE2012

Pituitary dysfunction in adult patients after cranial radiotherapy for non-pituitary tumors: a long-term follow-up study

Appelman-Dijkstra N. , Kokshoorn N. , Malgo F. , Neelis K. , Biermasz N. , Smit J. , Pereira A.

Background: Hypopituitarism after cranial radiotherapy for non-pituitary tumors is well recognized. However structured endocrine assessments are not incorporated into routine clinical practiceAim of the study: To evaluate pituitary function in adult patients irradiated for non-pituitary tumors at our centerPatients and Methods: Cross-sectional evaluation of pituitary function of all available patients treated with irradiation at ou...

ea0026p196 | Pituitary | ECE2011

Coping strategies in patients after treatment for functioning or non-functioning pituitary adenomas

Tiemensma J , Kaptein A A , Pereira A M , Smit J W A , Romijn J A , Biermasz N R

Context and objective: Coping strategies may affect quality of life (QoL), which is decreased in patients after treatment for Cushing’s disease, acromegaly, or non-functioning macroadenomas (NFMA). We aimed to explore coping strategies in these patients, since this has never been done before.Design: A cross sectional study.Subjects: We included patients treated for Cushing’s disease (n=42), for acromegaly (n...

ea0026p215 | Pituitary | ECE2011

Illness perceptions, quality of life and self-reported physical symptoms in patients after long-term remission of Cushing’s syndrome

Tiemensma J , Kaptein A A , Pereira A M , Smit J W A , Romijn J A , Biermasz N R

Context and objective: Illness perceptions pertain the pattern of beliefs patients develop about their illness. These views are determinants of behavior directed at the illness. Illness perceptions are determinants of quality of life (QoL). QoL remains impaired in patients after treatment of endogenous hypercortisolism, however, illness perceptions were never studied in these patients. The objective of the current study was to explore illness perceptions and its relation with ...

ea0026p233 | Pituitary | ECE2011

GH replacement therapy in elderly GH deficient patients: a systematic review

Kokshoorn N E , Biermasz N R , Roelfsema F , Smit J W A , Pereira A M , Romijn J A

Context: Recombinant human GH (rhGH) is indicated for the treatment of adult subjects with GH deficiency (GHD). However, conflicting data are available on the efficacy of rhGH treatment in elderly GHD patients.Objective: To assess the efficacy of rhGH treatment in elderly GHD subjects.Methods: We searched PubMed, Cochrane Library, Web of Science, and EMBASE.Study selection: Eligible studies included GHD patie...

ea0029p1423 | Pituitary Clinical | ICEECE2012

Progression of acromegalic arthropathy despite long-term biochemical control: a prospective, radiological study

Claessen K. , Ramautar S. , Pereira A. , Smit J. , Roelfsema F. , Romijn H. , Kroon H. , Kloppenburg M. , Biermasz N.

Background: Leiden University Medical Center, Leiden, The Netherlands; 2Leiden University Medical Center, Leiden, The Netherlands; 3Leiden University Medical Center, Leiden, The NetherlandsBackground: Arthropathy is an invalidating complication of acromegaly, despite persisting biochemical disease control, which has a high impact on the quality of life (QoL). The prognosis and determinants are currently unknown.<p class="abstext...

ea0026p134 | Growth factors | ECE2011

Circulating insulin-like growth factor 1 (IGF1) and mortality: meta-analysis and dose-response meta-regression

Burgers A M G , Biermasz N R , Schoones J W , Pereira A M , Renehan A G , Zwahlen M , Egger M , Dekkers O M

Background: Insulin-like growth factor 1 (IGF1) plays a central role in metabolism and growth regulation. High IGF1 levels are associated with an increased risk of cancer, low IGF1 levels with increased risk for cardiovascular disease. We hypothesized that the relationship between circulating total IGF1 levels and mortality is U-shaped.Methods: We performed a systematic review searching PubMed, EMBASE, Web of Science, Cochrane Library (1985 to September ...

ea0026p256 | Pituitary | ECE2011

Low incidence of adrenal insufficiency after transsphenoidal surgery in patients with acromegaly: a long-term follow-up study

Burgers A M G , Kokshoorn N E , Pereira A M , Roelfsema F , Smit J W A , Biermasz N R , Romijn J A

Background: The long-term prevalence of adrenal insufficiency after transsphenoidal surgery for GH secreting pituitary adenomas was unknown. However, recently a single study reported a high prevalence of adrenal insufficiency after surgical and/or medical treatment without postoperative radiotherapy in acromegalic patients.Aim: To assess the prevalence and incidence rate of adrenal insufficiency in consecutive patients during long-term follow-up after su...

ea0026p294 | Pituitary | ECE2011

Patients previously treated for nonfunctioning pituitary macroadenomas have disturbed sleep characteristics, circadian movement rhythm, and subjective sleep quality

Joustra S D , Biermasz N R , Donga E , Pereira A M , Van Duinen N , Van Dijk M , Van der Klaauw A A , Corssmit E P M , Lammers Gert Jan , Van Kralingen Klass , Van Dijk J G , Romijn J A

Context and objective: Fatigue and excessive sleepiness have been reported after treatment of nonfunctioning pituitary macroadenomas (NFMA). Because these complaints may be caused by disturbed nocturnal sleep, we evaluated objective sleep characteristics in patients treated for NFMA.Design: Controlled cross-sectional study.Subjects and methods: We studied 17 patients (8 women, mean age 54 years), in remission of NFMA during long-te...